IDEXX & Global Animal Testing: Competitive Landscape & Pricing Dynamics
Former Executive at IDEXX
inpractise.com/articles/petcare-testing-us-vs-international-market-practices
IDEXX & Global Animal Testing: Competitive Landscape & Pricing Dynamics(January 14, 2025)
Former Executive at IDEXX
Interview Transcript
This is a snippet of the transcript, sign up to read more.
How does pricing compare between the US and Europe usually? Do you have quantitative data?
The US is significantly higher in pricing. Two of the highest-priced regions in the international market are the Nordics, second to North America, followed by the UK, and then other European countries. I can provide more details depending on the country, but it becomes complex for providers and manufacturers in Europe due to cross-border trading and varying pricing in each country. There's no standardization of pricing across Europe.
This is a snippet of the transcript, sign up to read more.
Related Content
Idexx Laboratories: In-house vs Reference Labs for Independent Practices
Current Managing Director at Independent Veterinary Hospital
IDEXX Laboratories: UK Vet Practices, Diagnostics & Practice Management Software
Director at UK Independent Vet Practice
IDEXX: Antech / Heska Combination & Threat to IDEXX
Former Vice President at Heska
IDEXX : Abaxis Competition & Zoetis Integration
Former Vice President at Abaxis
Copyright Notice
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2025 IP 1 Ltd. All rights reserved.